REG - CVS Group plc - Exercise of Options and Total Voting Rights

CVSAnnouncement

28/03/2024 16:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240328:nRSb7867Ia&default-theme=true

RNS Number : 7867I  CVS Group plc  28 March 2024

28 March 2024

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
confirms that certain employees have exercised options during March under the
CVS Group 2020 SAYE Plan (2020/2024) totalling 8,299 ordinary shares of 0.2
pence each ("Ordinary Shares").

The sum of 8,299 new Ordinary Shares were issued to satisfy the balance of
Ordinary Shares arising from the SAYE Exercise.  Admission of the 8,299 new
Ordinary Shares has been satisfied by the Company's block listing admitted to
the London Stock Exchange on 30 December 2021.

Following the issue of these new Ordinary Shares, which rank pari passu in all
respects with the Company's existing Ordinary Shares, the Company has a total
issued share capital of 71,721,269 Ordinary Shares, each carrying one voting
right. The Company holds no Ordinary Shares in treasury and the total number
of voting rights is therefore 71,721,269.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny Pulbrook
                                                                                                 +44
(0)7961 315 138

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK, Australia, the Netherlands and the Republic of Ireland.  CVS is
focused on providing high-quality clinical services to its clients and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

 

 

 

The Group operates c.500 veterinary practices across its four territories,
including nine specialist referral hospitals and 39 dedicated out-of-hours
sites. Alongside the core Veterinary Practices division, CVS operates
Laboratories (providing diagnostic services to CVS and third-parties),
Crematoria (providing pet cremation and clinical waste disposal for CVS and
third-party practices) and the Group's online retail business ("Animed
Direct").

The Group employs c.9,100 personnel, including c.2,400 veterinary surgeons and
c.3,400 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBLGDXUGDDGSI